Mazzo David J

Mazzo David J is listed in filings as President & CEO at Lisata Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 13, 2026, including 14 public disclosures. Recent filings connect the profile to Lisata Therapeutics, Inc. (LSTA). The current snapshot covers public activity from Oct 2, 2024 to Jan 13, 2026. Reported amounts are shown as $78.8K to $20.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.